Ocean Biomedical, Inc.
OCEA
$0.04
-$0.0015-3.61%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 3.77M | 1.38M | 2.96M | 5.08M | 9.51M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.80M | 1.39M | 3.27M | 5.42M | 10.21M |
| Operating Income | -3.80M | -1.39M | -3.27M | -5.42M | -10.21M |
| Income Before Tax | -9.48M | -26.62M | -35.18M | -29.38M | -114.47M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -9.48 | -26.62 | -35.18 | -29.38 | -114.47 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -9.48M | -26.62M | -35.18M | -29.38M | -114.47M |
| EBIT | -3.80M | -1.39M | -3.27M | -5.42M | -10.21M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.34 | -0.97 | -1.30 | -1.11 | -4.48 |
| Normalized Basic EPS | -0.21 | -0.61 | -0.81 | -0.66 | -2.43 |
| EPS Diluted | -0.34 | -0.97 | -1.30 | -1.11 | -4.48 |
| Normalized Diluted EPS | -0.21 | -0.61 | -0.81 | -0.66 | -2.43 |
| Average Basic Shares Outstanding | 109.99M | 109.55M | 108.67M | 107.65M | 105.13M |
| Average Diluted Shares Outstanding | 109.99M | 109.55M | 108.67M | 107.65M | 105.13M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |